Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1741 AL 1755

Rhythmic movement in Parkinson's disease: effects of visual feedback and medication state

Levy-Tzedek S, Krebs HI, Arle JE, Shils JL, Poizner H.

Exp Brain Res. 2011 Jun;211(2):277-86. doi: 10.1007/s00221-011-2685-0. Epub 2011 Apr 28.

[Insufficient medication compliance in Parkinson's disease]

Aerts MB, van der Eijk M, Kramers K, Bloem BR.

Ned Tijdschr Geneeskd. 2011;155:A3031.

The ALS/PDC syndrome of Guam: potential biomarkers for an enigmatic disorder

McGeer PL, Steele JC.

Prog Neurobiol. 2011 Dec;95(4):663-9. doi: 10.1016/j.pneurobio.2011.04.001. Epub 2011 Apr 20.

Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease

Maraganore DM.

J Mov Disord. 2011 May;4(1):1-7. doi: 10.14802/jmd.11001. Epub 2011 Apr 30.

[Anaesthesia and Parkinson's disease]

Chhor V, Karachi C, Bonnet AM, Puybasset L, Lescot T.

Ann Fr Anesth Reanim. 2011 Jul-Aug;30(7-8):559-68. doi: 10.1016/j.annfar.2011.02.012. Epub 2011 Apr 29.

Attenuation of apomorphine-induced sensitization by buspirone

Ikram H, Haleem DJ.

Pharmacol Biochem Behav. 2011 Sep;99(3):444-50. doi: 10.1016/j.pbb.2011.04.007. Epub 2011 Apr 17.

Inverted-U-shaped dopamine actions on human working memory and cognitive control

Cools R, D'Esposito M.

Biol Psychiatry. 2011 Jun 15;69(12):e113-25. doi: 10.1016/j.biopsych.2011.03.028. Epub 2011 May 4.

Ongoing challenges to finding people with Parkinson's disease for epidemiological studies: a comparison of population-level case ascertainment methods

Harris MA, Koehoorn M, Teschke K.

Parkinsonism Relat Disord. 2011 Jul;17(6):464-9. doi: 10.1016/j.parkreldis.2011.04.007. Epub 2011 May 4.

Myasthenia gravis as a cause of head drop in Parkinson disease

Uludag IF, Korucuk M, Sener U, Zorlu Y.

Neurologist. 2011 May;17(3):144-6. doi: 10.1097/NRL.0b013e3182173356.

Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images

Meyer PT, Winz OH, Dafotakis M, Werner CJ, Krohn T, Schäfer WM.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):301-9.

Priorities in Parkinson's disease research

Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E.

Nat Rev Drug Discov. 2011 May;10(5):377-93. doi: 10.1038/nrd3430.

Manganese accumulation in the CNS and associated pathologies

Rivera-Mancía S, Ríos C, Montes S.

Biometals. 2011 Oct;24(5):811-25. doi: 10.1007/s10534-011-9454-1. Epub 2011 May 1.

To be or not to be accepted: the role of immunogenicity of neural stem cells following transplantation into the brain in animal and human studies

Capetian P, Döbrössy M, Winkler C, Prinz M, Nikkhah G.

Semin Immunopathol. 2011 Nov;33(6):619-26. doi: 10.1007/s00281-011-0272-x. Epub 2011 May 1.

Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease

Müller T, Woitalla D, Muhlack S.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Jun;383(6):627-33. doi: 10.1007/s00210-011-0629-7. Epub 2011 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias